We are live on
!
Find out more
GVI
Green Valley Investors Portfolio holdings
AUM
$1.76B
1-Year Est. Return
5.64%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
+5.64%
3 Year Est. Return
+59.43%
5 Year Est. Return
+81.11%
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$519M
(+13%)
Cap. Flow
+$92.5M
Cap. Flow
% of AUM
2.02%
Top 10 Holdings %
Top 10 Hldgs %
60.38%
Holding
26
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$83.6M |
| 2 |
Walmart Inc
WMT
|
+$38.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.78% |
| 2 | Materials | 18.88% |
| 3 | Consumer Staples | 15.71% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Communication Services | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESRX
1
DELISTED
Express Scripts Holding Company
ESRX
| $636M | 13.87% |
9,050,000
| – | – |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $389M | 8.48% |
4,600,000
| – | – |
|
3
Johnson & Johnson
JNJ
$643B
| $332M | 7.24% |
3,625,000
| – | – |
|
4
DuPont de Nemours
DD
$19B
| $275M | 6.01% |
2,448,263
| – | – |
|
|
5
Walmart Inc
WMT
$900B
| $236M | 5.15% |
9,000,000
+1,500,000
| +20% | +$38.7M |
|
6
TJX Companies
TJX
$178B
| $191M | 4.17% |
6,000,000
| – | – |
|
|
7
Thermo Fisher Scientific
TMO
$214B
| $189M | 4.13% |
1,700,000
-300,000
| -15% | -$29.8M |
|
8
Sysco
SYY
$40.8B
| $180M | 3.94% |
5,000,000
| – | – |
|
|
POT
9
DELISTED
Potash Corp Of Saskatchewan
POT
| $173M | 3.78% |
5,250,000
| – | – |
|
10
Stryker
SYK
$133B
| $165M | 3.61% |
2,200,000
| – | – |
|
|
BBBY
11
DELISTED
Bed Bath & Beyond Inc
BBBY
| $161M | 3.5% |
2,000,000
| – | – |
|
12
Comcast
CMCSA
$85.8B
| $151M | 3.29% |
5,800,000
| – | – |
|
13
International Flavors & Fragrances
IFF
$20.2B
| $146M | 3.19% |
1,700,000
| – | – |
|
14
Target
TGT
$65.5B
| $146M | 3.18% |
2,300,000
| – | – |
|
15
AbbVie
ABBV
$465B
| $142M | 3.09% |
2,680,000
| – | – |
|
16
Vertex Pharmaceuticals
VRTX
$124B
| $133M | 2.9% |
1,791,786
| – | – |
|
17
Marriott International
MAR
$101B
| $130M | 2.84% |
2,634,371
| – | – |
|
18
The Mosaic Company
MOS
$7.34B
| $123M | 2.68% |
2,600,000
| – | – |
|
19
Procter & Gamble
PG
$347B
| $112M | 2.45% |
1,380,000
| – | – |
|
20
Henry Schein
HSIC
$9.76B
| $103M | 2.24% |
2,295,000
| – | – |
|
21
Abbott
ABT
$187B
| $103M | 2.24% |
2,680,000
| – | – |
|
|
22
Gilead Sciences
GILD
$167B
| $90.1M | 1.97% |
+1,200,000
| New | +$83.6M |
|
23
Air Products & Chemicals
APD
$65.2B
| $89.4M | 1.95% |
864,800
| – | – |
|
24
Walt Disney
DIS
$172B
| $84M | 1.83% |
1,100,000
| – | – |
|
|
MON
25
DELISTED
Monsanto Co
MON
| $58.3M | 1.27% |
500,000
| – | – |
|
Similar funds
GMI
BA
AWM
CA
CC
STMM
RCM
BCMNY
Green Valley Investors's Q4 2013 Portfolio in Review
As of Q4 2013, Green Valley Investors held 26 positions worth $4.58B, up 13% from $4.06B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Trading was light in Q4 2013: portfolio turnover was 3.8%. Green Valley Investors opened 1 new position and made no exits, leaving the 26-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 49% a quarter earlier, followed by Materials and Consumer Staples.
- Green Valley Investors's largest Q4 2013 buy was Gilead Sciences: 1,200,000 shares worth $90.1M.
- Green Valley Investors added most to Walmart Inc in Q4 2013, an estimated $38.7M increase.
- Green Valley Investors's biggest Q4 2013 reduction was Thermo Fisher Scientific, cutting an estimated $29.8M.
- Green Valley Investors's ten largest holdings make up 60% of its $4.58B portfolio in Q4 2013.
- Green Valley Investors opened 1 new position and closed 0 in Q4 2013.
- Green Valley Investors's portfolio value rose 13% quarter-over-quarter to $4.58B.
Based on Green Valley Investors's 13F filing for Q4 2013, filed 13 Feb 2014.